Conclusion
RFA has been shown to provide oncologically effective cancer control in the presence of
international literature and in our series, with short, medium and long follow-up studies.
MWA-related studies will take place more in the literature in the near future. Today,
extirpative treatments (partial nephrectomy, radical nephrectomy) are the gold standard
method for the treatment of T1a renal cancer. However, for this treatment approach to be
used more frequently in routine practice, more comprehensive, long-term results and
prospective design studies are needed. As the long-term consequences of these methods arise,
the location of ablative techniques in the treatment of renal tumors will become even clearer.